RADIATION THERAPY (RT) AND TEMOZOLAMIDE (TMZ) AS ADJUVANT THERAPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM). PRELIMINARY DATA

被引：0
|
作者：
Iodice, G. [1 ]
Fusco, V. [2 ]
Tartarone, A. [1 ]
Bochicchio, A. M. [1 ]
Capobianco, A. [1 ]
Coccaro, M. R. [1 ]
Di Leo, P. [1 ]
Romano, G. P. [1 ]
Castaldo, G. [2 ]
Montagna, A. [2 ]
Lapadula, L. [2 ]
机构：
[1] Ctr Riferimento Oncol, Hematol Oncol Unit, Rionero In Vulture, PZ, Italy
[2] Ctr Riferimento Oncol, Radiotherapy Unit, Rionero In Vulture, PZ, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [21] Results of a Prospective Trial Evaluating Accelerated Radiation Therapy using Tomotherapy Simultaneous Integrated Boost (ARTOSIB) with Concurrent and Adjuvant Temozolomide (TMZ) Chemotherapy in the Treatment of Glioblastoma Multiforme (GBM)
    AlHussain, H.
    Malone, S.
    Gertler, S.
    Nguyen, T.
    Nicholas, G.
    Page, N.
    Woulfe, J.
    Agboola, O.
    Montgomery, L.
    Caudrelier, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S270 - S271
  • [22] PSEUDOPROGRESSION (PSPR) AFTER CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Clarke, Jennifer
    Abrey, Lauren
    Karimi, Sasan
    Lassman, Andrew
    NEURO-ONCOLOGY, 2008, 10 (05) : 893 - 893
  • [23] Phase II trial for patients with newly diagnosed glioblastoma (GBM) treated with carmustine wafers followed by concurrent radiation therapy (RT), temozolomide (TMZ), and bevacizumab (BV), then followed by TMZ and BV post-RT.
    Ranjan, Tulika
    Peters, Katherine B.
    Vlahovic, Gordana
    Alderson, Lloyd M.
    Herndon, James Emmett
    McSherry, Frances
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Bigner, Darell D.
    Friedman, Henry S.
    Vredenburgh, James J.
    Desjardins, Annick
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Pseudoprogression (PsPr) after concurrent radiotherapy (RT) and temozolomide (TMZ) for newly diagnosed glioblastoma multiforme (GBM)
    Clarke, J. L.
    Abrey, L. E.
    Karimi, S.
    Lassman, A. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM
    Alexander, Brian
    Supko, Jeffrey
    Agar, Nathalie
    Ahluwalia, Manmeet
    Desai, Arati
    Dietrich, Jorg
    Kaley, Thomas
    Peereboom, David
    Takebe, Naoko
    Desideri, Serena
    Fisher, Joy
    Sims, Megan
    Ye, Xiaobu
    Ligon, Keith
    Nabors, L. Burt
    Grossman, Stuart
    Wen, Patrick
    NEURO-ONCOLOGY, 2018, 20 : 13 - 14
  • [26] Practical immunomodulatory landscape of glioblastoma multiforme (GBM) therapy
    Norollahi, Seyedeh Elham
    Yousefi, Bahman
    Nejatifar, Fatemeh
    Yousefzadeh-Chabok, Shahrokh
    Rashidy-pour, Ali
    Samadani, Ali Akbar
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2024, 36 (01)
  • [27] Toxicity of concurrent and adjuvant temozolomide in patients with glioblastoma multiforme (GBM).
    Mcmahon, David
    Hussein, Awab
    Mangleburg, Hunter
    Nichianain, Aine
    Fitzpatrick, Orla
    McLaughlin, Ronan Andrew
    Conroy, Michael R.
    Marks, Sam Jonathan
    Naidoo, Jarushka
    Grogan, William
    Murphy, Adrian Gerard
    Breathnach, Oscar S.
    Hennessy, Bryan T.
    Morris, Patrick G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) PLUS RADIATION THERAPY (RT) PLUS TEMOZOLAMIDE (TMZ) COMPARED TO RT PLUS TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Ben Harosh, Carmit
    Blumenthal, Deborah
    Ram, Zvi
    NEURO-ONCOLOGY, 2020, 22 : 196 - 196
  • [29] A Phase 2 Trial of Neoadjuvant Temozolomide (TMZ) Followed By Accelerated Hypofractionated Radiation Therapy (AHRT) and TMZ Followed By Adjuvant TMZ in Patients with Newly Diagnosed Glioblastoma (GBM): Long Term Survival and Toxicity Analysis
    Shenouda, G.
    Souhami, L.
    Petrecca, K.
    Owen, S.
    Panet-Raymond, V.
    Carvalho, T.
    Guiot, M. C.
    Abdulkarim, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S48 - S49
  • [30] Effect of combined therapy with temsirolimus (CCI-779), temozolomide (TMZ), and radiation (RT) in newly diagnosed glioblastoma multiforme (GBM) patients on immune suppression: Results from NCCTG N027D
    Sarkaria, J. N.
    Galanis, E.
    Gustafson, M. P.
    Dietz, A. B.
    Wu, W.
    Brown, P. D.
    Uhm, J. H.
    Giannini, C.
    Jaeckle, K. A.
    Buckner, J. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345